Gramicidin
Who holds supplier records for Gramicidin? 2 organisations hold a current record for Gramicidin: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 1 of them holds a valid EU Certificate of Suitability. Recorded organisation countries for current records: Denmark (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Gramicidin: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/gramicidin
Reading the evidence
- 2 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 1 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (2)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Gramicidin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Xellia PharmaceuticalsDenmarkCEP Company GMP cert on recordActive DMF 17538 · latest filing Jul 2004
- ZHEJIANG HUIDA BIOTECH CO LTDActive DMF 44218 · latest filing Sept 2026
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (1)
Certificates of Suitability on the EDQM register for Gramicidin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| XELLIA PHARMACEUTICALS LTD. Budapest X | HU | CEP 2006-132 - Rev 07 Gramicidin | Jul 2026 | Inspected Jul 2025 Hungary |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (3)
Organisations whose Type II DMFs for Gramicidin are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- AXELLIA PHARMACEUTICALS ASInactive DMF 13494 · filed Sept 1998
- GIST-BROCADES NV PHARMACEUTICALSInactive DMF 13337 · filed Sept 1998
- PENICK CORPInactive DMF 201 · filed Jan 1940
Overview
Gramicidin is a unknown active pharmaceutical ingredient (ChEMBL CHEMBL1201469).
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Gramicidin?
2 organisations hold an active US FDA Type II Drug Master File or a CEP for Gramicidin: Xellia Pharmaceuticals (Denmark) and ZHEJIANG HUIDA BIOTECH CO LTD. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Gramicidin Drug Master Files are active?
Xellia Pharmaceuticals (DMF 17538) and ZHEJIANG HUIDA BIOTECH CO LTD (DMF 44218). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Gramicidin records mean?
3 organisations have only inactive Type II DMFs for Gramicidin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Gramicidin have a European Certificate of Suitability?
Yes. 1 organisation holds a valid CEP for Gramicidin on the EDQM register, including XELLIA PHARMACEUTICALS LTD. Budapest X (HU). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Gramicidin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Gramicidin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.